Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type, indication, end-user and route of administration, Region And Segment Forecasts, 2023-2031

Medical Nutrition Market Size is valued at USD 13.1 Bn in 2023 and is predicted to reach USD 20.2 Bn by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031.

The escalating occurrence of malnutrition among adults and the surge in obesity rates, coupled with the increasing prevalence of chronic diseases like cancer and diabetes, are primary drivers propelling market growth. Oral clinical nutrition, comprising vitamins, proteins, and carbohydrates in various forms such as powder, liquid, and semi-solid, is witnessing significant demand for oral consumption. Leading market players in the manufacturing of oral clinical nutrition products are innovating with new flavors to improve taste, thereby expanding their customer base and boosting product sales. This, in turn, drives market demand. The increasing incidence of cancer cases has heightened the need for nutritious food, driven by the adverse effects of cancer treatment, including appetite loss and malnutrition issues among adults, such as depletion of essential body nutrition proteins and vitamins.

Competitive Landscape

Some of the major key players in the Medical Nutrition market are

• Abbott,
• Danone S.A.
• Baxter
• Nestlé
• GSK plc.
• Sun Pharmaceutical Industries Ltd.
• Sanofi
• DSM
• BASF SE
• Fresenius SE & Co. KGaA
• Leprino Foods Company
• Fresenius Kabi Ltd
• Sparer Onco Nutrition
• Kate Farms
• Guardion Health Sciences, Inc.
• Other Prominent Players

Market Segmentation:

The Medical Nutrition market is segmented on the basis of nutrition, patient type, indication, end-user and route of administration. Nutrition type segment includes proteins, carbohydrates, multi-vitamins and antioxidants, amino acids, fibers, minerals, and other. By patient type, the market is segmented as infants, adults, and geriatric populations. By indication, the market is segmented as diabetes, cancer, gastrointestinal diseases, metabolic syndromes, and other medical disorders. By end user, the market is segmented as hospitals, home care settings, long-term care facilities, and ambulatory surgical centers. By route of administration, categorized between oral, enteral, and parenteral delivery methods.

Based On Product, The Segment Is Accounted As A Major Contributor In The Medical Nutrition Market

In the medical nutrition market, the Cancer segment is anticipated to hold a dominant position based on indication. This is mainly due to the substantial prevalence of cancer globally, with it being the second leading cause of death worldwide. Cancer patients often experience various nutritional challenges, including weight loss, malnutrition, and difficulty in eating, which can negatively impact their overall health and treatment outcomes. Consequently, there is an increasing acceptance of the significance of specialized nutritional support for cancer patients in order to facilitate the efficacy of cancer treatments, manage symptoms, enhance the quality of life, and address their unique dietary requirements, including chemotherapy and radiation therapy. Consequently, the Cancer segment is anticipated to hold a notable share of the medical nutrition market as healthcare providers continue emphasising nutritional interventions as a crucial aspect of comprehensive cancer care.

Geriatric Nutrition Segment Witnessed Growth At A Rapid Rate

In the medical nutrition market, the Geriatric Nutrition segment is poised to maintain a leading position primarily due to the significant increase in the global geriatric population. As demographics shift towards an aging population worldwide, there's a corresponding rise in the prevalence of age-related health conditions and nutritional challenges among the elderly.Geriatric individuals often face unique dietary needs and challenges due to factors such as decreased appetite, changes in metabolism, and a higher risk of chronic diseases. Consequently, there's an increased demand for specialized nutritional products and services tailored to address these specific needs and support optimal health outcomes among older adults.

In The Region, The North America Medical Nutrition Market Holds Significant Revenue Share.

The growing population of individuals affected by non-communicable diseases like diabetes, hypertension, cancer, and chronic kidney diseases (CKDs) is anticipated to drive demand for oral clinical nutritional products in this area. Additionally, the increasing efforts among pharmaceutical and food & nutrition companies to broaden their product portfolios fuel this segment's growth. The Asia Pacific region is expected to experience rapid growth during the forecast period. This can be attributed to the development of healthcare infrastructure, improved healthcare reimbursement policies, government initiatives in the healthcare sector, and favourable economic growth, all of which contribute positively to market expansion. Furthermore, the presence of prominent players in this region is a significant factor driving regional growth. 

Medical Nutrition Market Report Scope: